Adjuvant Chemotherapy in Patients With Stage I-IIIA Large-Cell Neuroendocrine Carcinoma: Should a Different Approach Be Applied Than for Small-Cell Lung Cancer?

Jules L. Derks; Ernst Jan M. Speel; Anne Marie C. Dingemans

doi:10.1200/jco.20.03598

Adjuvant Chemotherapy in Patients With Stage I-IIIA Large-Cell Neuroendocrine Carcinoma: Should a Different Approach Be Applied Than for Small-Cell Lung Cancer?

Jules L. Derks, Ernst Jan M. Speel, Anne Marie C. Dingemans^*

^*Corresponding author for this work

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	1508-1509
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	39
Issue number	13
DOIs	https://doi.org/10.1200/jco.20.03598
Publication status	Published - 1 May 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/jco.20.03598

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.03598

Cite this

@article{281dcd40eb564e31bd7d25a13ac87f31,

title = "Adjuvant Chemotherapy in Patients With Stage I-IIIA Large-Cell Neuroendocrine Carcinoma: Should a Different Approach Be Applied Than for Small-Cell Lung Cancer?",

author = "Derks, {Jules L.} and Speel, {Ernst Jan M.} and Dingemans, {Anne Marie C.}",

year = "2021",

month = may,

day = "1",

doi = "10.1200/jco.20.03598",

language = "English",

volume = "39",

pages = "1508--1509",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "13",

}

Adjuvant Chemotherapy in Patients With Stage I-IIIA Large-Cell Neuroendocrine Carcinoma: Should a Different Approach Be Applied Than for Small-Cell Lung Cancer? / Derks, Jules L.; Speel, Ernst Jan M.; Dingemans, Anne Marie C.
In: Journal of Clinical Oncology, Vol. 39, No. 13, 01.05.2021, p. 1508-1509.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Adjuvant Chemotherapy in Patients With Stage I-IIIA Large-Cell Neuroendocrine Carcinoma

T2 - Should a Different Approach Be Applied Than for Small-Cell Lung Cancer?

AU - Derks, Jules L.

AU - Speel, Ernst Jan M.

AU - Dingemans, Anne Marie C.

PY - 2021/5/1

Y1 - 2021/5/1

UR - http://www.scopus.com/inward/record.url?scp=85105835713&partnerID=8YFLogxK

U2 - 10.1200/jco.20.03598

DO - 10.1200/jco.20.03598

M3 - Article

C2 - 33661698

AN - SCOPUS:85105835713

SN - 0732-183X

VL - 39

SP - 1508

EP - 1509

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 13

ER -

Adjuvant Chemotherapy in Patients With Stage I-IIIA Large-Cell Neuroendocrine Carcinoma: Should a Different Approach Be Applied Than for Small-Cell Lung Cancer?

UN SDGs

Access to Document

Other files and links

Cite this